D
Cullinan Therapeutics, Inc. CGEM
$9.07 $0.111.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 9.67% 36.84% 21.55% 34.80% 15.79%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 27.93% 21.02% 9.04% 33.03% -31.50%
Operating Income -27.93% -21.02% -9.04% -33.03% 31.50%
Income Before Tax -29.89% -19.77% -3.51% -30.47% 35.78%
Income Tax Expenses -- 100.83% -- -- --
Earnings from Continuing Operations -29.89% -86.39% -3.51% -30.47% 35.78%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -100.00% -- -- 7.26%
Net Income -30.56% -100.17% -3.51% -30.47% 35.91%
EBIT -27.93% -21.02% -9.04% -33.03% 31.50%
EBITDA -27.98% -21.06% -9.07% -33.11% 31.54%
EPS Basic 4.67% -46.24% 24.17% 5.32% 39.38%
Normalized Basic EPS 4.37% 5.83% 23.31% 5.32% 39.46%
EPS Diluted 4.67% -46.24% 24.17% 5.32% 39.38%
Normalized Diluted EPS 4.37% 5.83% 23.31% 5.32% 39.46%
Average Basic Shares Outstanding 36.95% 36.89% 36.51% 37.80% 5.72%
Average Diluted Shares Outstanding 36.95% 36.89% 36.51% 37.80% 5.72%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --